Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase‐derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance

LA-derived sEH metabolite (diol) to substrate (epoxide) ratio was lower in individuals with diabetes. The diol/epoxide ratio with high HbA1c contributed to SVD and brain atrophy. The CYP450-sEH pathway may link metabolic and vascular contributions to dementia. sEH may be a potential therapeutic target in individuals with diabetes.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-10-01
DOI
https://doi.org/10.1002/alz.70718
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase‐derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance

Anthony E. Lang, Hugo Cogo‐Moreira, Bradley J. MacIntosh, Stephen R. Arnott et al.
Alzheimer s & Dementia
Eicosanoids and Hypertension Pharmacology
article

Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase‐derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance

Anthony E. Lang, Hugo Cogo‐Moreira, Bradley J. MacIntosh, Stephen R. Arnott, Nuanyi Liang, Robert A. Hegele, Ameer Y. Taha, Jennifer S. Rabin, Maged Goubran, Sean Symons, Krista L. Lanctôt, Julie Ottoy, Walter Swardfager, Anthony M. Magliocco, Joel Ramirez, Natasha Z. Anita, Myuri Ruthirakuhan, William Z. Lin, Yuen Yan Wong, Si Won Ryoo, C. Huang, Sofia E. Perfetto
article en

Abstract

LA-derived sEH metabolite (diol) to substrate (epoxide) ratio was lower in individuals with diabetes. The diol/epoxide ratio with high HbA1c contributed to SVD and brain atrophy. The CYP450-sEH pathway may link metabolic and vascular contributions to dementia. sEH may be a potential therapeutic target in individuals with diabetes.

Alzheimer s & DementiaVol. 21(10)
Western University (CA), Sunnybrook Health Science Centre (CA), University Health Network (CA), University of Toronto (CA), Østfold University of Applied Sciences (NO), Toronto Western Hospital (CA), Toronto Rehabilitation Institute (CA), Health Sciences Centre (CA), University of California San Diego (US), Occupational Cancer Research Centre (CA), Indoc Research (CA), Sunnybrook Hospital (CA), Krembil Research Institute, Sunnybrook Research Institute, University of California, Davis (US)
Alzheimer's Association, Eli Lilly and Company, BrightFocus Foundation, University of Ottawa, Fondation Brain Canada, McMaster University, Weston Brain Institute, Government of Ontario, Centre for Addiction and Mental Health Foundation, Fondation Leducq, Canada Research Chairs, Queen's University, University of Toronto, Temerty Family Foundation, Ministry of Colleges and Universities, National Institute of Food and Agriculture, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Banting and Best Diabetes Centre, University of Toronto, Faculty of Health Sciences, Queen's University
Openalex Percentile: Top 73%
Eicosanoids and Hypertension Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.